Skip to content

OncoBeta Rhenium Skin Cancer Therapy (Rhenium-SCT)

by OncoBeta GmbH

Ref 0500

Active European Union

CE MDR

Valid until

Not listed

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number++B952RECSCT35 Basic UDI-DI B95205000UDI-DIDate22 Aug 2025RegisteredStatusActive

Certificates

0 certificates · EUDAMED

EUDAMED lists no certificate for this device's Basic UDI-DI.

A certificate issued for a device group may exist without being linked here.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Specification

EUDAMED

Device Name
OncoBeta Rhenium Skin Cancer Therapy (Rhenium-SCT)
Model / Reference
0500
Primary DI / UDI-DI
B95205000
Basic UDI-DI
++B952RECSCT35
EMDN Code
Z11010301 Brachytherapy radiation systems
Device Class
Class IIb
Medical Purpose
To treat BCC and SCC skin cancer lesions and tumours.

Manufacturer details

EUDAMED SRN
DE-PR-000042688

Other devices from OncoBeta GmbH

Properties

Other properties (1)

  • Sterile: No